title: Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.
abstract: The epithelial-to-mesenchymal transition (EMT) is an embryonic process that becomes latent in most normal adult tissues. Recently, we have shown that induction of EMT endows breast epithelial cells with stem cell traits. In this report, we have further characterized the EMT-derived cells and shown that these cells are similar to mesenchymal stem cells (MSCs) with the capacity to differentiate into multiple tissue lineages. For this purpose, we induced EMT by ectopic expression of Twist, Snail, or transforming growth factor-beta in immortalized human mammary epithelial cells. We found that the EMT-derived cells and MSCs share many properties including the antigenic profile typical of MSCs, that is, CD44(+), CD24(-), and CD45(-). Conversely, MSCs express EMT-associated genes, such as Twist, Snail, and mesenchyme forkhead 1 (FOXC2). Interestingly, CD140b (platelet-derived growth factor receptor-beta), a marker for naive MSCs, is exclusively expressed in EMT-derived cells and not in their epithelial counterparts. Moreover, functional analyses revealed that EMT-derived cells but not the control cells can differentiate into alizarin red S-positive mature osteoblasts, oil red O-positive adipocytes and alcian blue-positive chondrocytes similar to MSCs. We also observed that EMT-derived cells but not the control cells invade and migrate towards MDA-MB-231 breast cancer cells similar to MSCs. In vivo wound homing assays in nude mice revealed that the EMT-derived cells home to wound sites similar to MSCs. In conclusion, we have demonstrated that the EMT-derived cells are similar to MSCs in gene expression, multilineage differentiation, and ability to migrate towards tumor cells and wound sites.
authors.affiliation: Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation, The University of Texas-M.D. Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Venkata Lokesh
authors.initials: VL
authors.lastname: Battula
authors.forename: Kurt William
authors.initials: KW
authors.lastname: Evans
authors.forename: Brett George
authors.initials: BG
authors.lastname: Hollier
authors.forename: Yuexi
authors.initials: Y
authors.lastname: Shi
authors.forename: Frank C
authors.initials: FC
authors.lastname: Marini
authors.forename: Ayyakkannu
authors.initials: A
authors.lastname: Ayyanan
authors.forename: Rui-Yu
authors.initials: RY
authors.lastname: Wang
authors.forename: Cathrin
authors.initials: C
authors.lastname: Brisken
authors.forename: Rudy
authors.initials: R
authors.lastname: Guerra
authors.forename: Michael
authors.initials: M
authors.lastname: Andreeff
authors.forename: Sendurai A
authors.initials: SA
authors.lastname: Mani
mesh_terms: D017667:Adipocytes / Q000166:cytology; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology*; D002478:Cells, Cultured; D020219:Chondrogenesis / Q000235:genetics / Q000502:physiology; D058750:Epithelial-Mesenchymal Transition / Q000235:genetics / Q000502:physiology*; D005434:Flow Cytometry; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D010006:Osteoblasts / Q000166:cytology; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D020797:Receptor, Platelet-Derived Growth Factor beta